Detalhe da pesquisa
1.
Emergency room neurology in times of COVID-19: malignant ischaemic stroke and SARS-CoV-2 infection.
Eur J Neurol
; 27(9): e35-e36, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32352618
2.
Spanish consensus on the use of natalizumab (Tysabri®)-2013.
Neurologia
; 30(5): 302-14, 2015 Jun.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-24360652
3.
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Neurologia
; 28(6): 375-8, 2013.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-23643683
4.
Early beginning of alemtuzumab: Changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study.
Neurologia (Engl Ed)
; 2023 Apr 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37116693
5.
Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain.
Pharmacoecon Open
; 7(3): 431-441, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36802327
6.
[15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part II)]. / XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II).
Rev Neurol
; 77(2): 47-60, 2023 07 16.
Artigo
Espanhol
| MEDLINE | ID: mdl-37403243
7.
[Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry (2018-2022)]. / Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022).
Rev Neurol
; 76(12): 377-383, 2023 06 16.
Artigo
Espanhol
| MEDLINE | ID: mdl-37303099
8.
[15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part I)]. / XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I).
Rev Neurol
; 77(1): 19-30, 2023 07 01.
Artigo
Espanhol
| MEDLINE | ID: mdl-37365721
9.
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Mult Scler
; 18(7): 983-90, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22183936
10.
Spanish consensus on the use of natalizumab (Tysabri(®))--2011.
Neurologia
; 27(7): 432-41, 2012 Sep.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-22078648
11.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.
Neurologia (Engl Ed)
; 37(8): 615-630, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36195374
12.
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain. / Consenso de expertos sobre el uso de alemtuzumab en la práctica clínica diaria en España.
Neurologia (Engl Ed)
; 37(8): 615-630, 2022 10.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-31987648
13.
Neurophysiology training in the Neurology Specialist Education Program in Spain.
Neurologia
; 26(5): 272-8, 2011 Jun.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-21339026
14.
[Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum]. / Determinación plasmática de neurofilamentos como biomarcador en la esclerosis múltiple: conclusiones del foro EMotion.
Rev Neurol
; 73(3): 101-110, 2021 Aug 01.
Artigo
Espanhol
| MEDLINE | ID: mdl-34291447
15.
Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
PLoS One
; 16(10): e0258437, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34644366
16.
13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I). / XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (I).
Rev Neurol
; 72(11): 397-406, 2021 06 01.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-34042168
17.
13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (II). / XIII Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2020 (II).
Rev Neurol
; 72(12): 433-442, 2021 Jun 16.
Artigo
Espanhol, Inglês
| MEDLINE | ID: mdl-34109999
18.
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement. / Recomendaciones para la vacunación en pacientes con esclerosis múltiple candidatos a terapias inmunosupresoras: documento de consenso español.
Neurologia (Engl Ed)
; 36(1): 50-60, 2021.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-32561334
19.
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
Mult Scler
; 16(2): 139-46, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-20007426
20.
Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey. / ¿Va a cambiar la neurología tras la pandemia de COVID-19 en los próximos 5 años? Estudio de enfoque mediante informadores clave.
Neurologia (Engl Ed)
; 35(4): 252-257, 2020 May.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-32364126